Videos

Video Übersicht

Social Media

Facebook

Bayer   Second quarter of 2016:
Bayer raises sales and earnings

The Bayer Group posted further growth in the second quarter of 2016. “Our Life Science businesses recorded encouraging sales and earnings growth overall,” said CEO Werner Baumann when he presented the interim report for the second quarter on Wednesday. At Pharmaceuticals, Bayer benefited from the continued strong development of the recently launched products. Consumer Health increased sales, while EBITDA before special items receded. Sales of Crop Science held steady at the prior-year level despite a continuingly difficult market environment, while earnings decreased. EBITDA before special items at Animal Health declined despite sales growth. Covestro registered a substantial increase in EBITDA before special items, while sales fell as expected. “We remain confident about the year as a whole and are raising the Group forecast,” said Baumann.

See Full Interim Report for Second Quarter 2016:
http://www.quarterly-report-2016-q2.bayer.com/
27. Juli 2016
Bayer   “You don’t really think about research and medicine – until it actually affects you.”

A year ago, the world of André Simmons from Denver was nearly perfect: He was heading toward a career as a successful basketball star and his wife was expecting their first child. Then he was diagnosed with a cardiovascular disease that leads to death in every third person. Today, he is able to speak openly about that time because he has found a new passion.

Cardiovascular diseases are among the world’s main health problems and one of the most common causes of death. According to World Health Organization statistics, almost one in three people dies from some form of respiratory illness or cardiovascular disease including myocardial infarction and stroke. Many of these diseases and their often life-threatening consequences could be avoided by effective prevention.

Learn more about prevention and treatment of cardiovascular diseases:
http://www.bayer.com/en/heart-attack-treatment-and-prevention.aspx
26. Juli 2016
Bayer   Promoting Pioneers in Science & Society

The world needs pioneers. That is why these two foundations have been committed to supporting clever individuals for over a century. They promote people and projects that make outstanding contributions in the fields of research, education and health as well as social ventures.

The Bayer Foundations see themselves as a source of inspiration and partner for progress. They support young talents, top researchers, social entrepreneurship and social commitment with their various programs and awards.

Learn more in this video:
https://www.youtube.com/watch?v=5mnd0iBsJek
26. Juli 2016
Bayer   Have a nice weekend, everybody! :)22. Juli 2016
Bayer   Twelve Months of Friendship

“Mexico Year” has been taking place in Germany since April 2016, following an initiative by the German Government under the leadership of the Department of Foreign Affairs and in cooperation with the Federation of German Industries (BDI) and the Goethe Institute. At the same time, “Germany Year” is underway in Mexico. Under the motto “Alliance for the Future”, both countries are working toward an improved mutual understanding, combining economic and political as well as cultural aspects. For example, as part of the newly-formed joint governmental commission, they aim to work on solutions to overcome global challenges. Around 120 projects including more than 1,000 individual events are taking place in the fields of culture, politics and the economy.

One example is the “EXPO Hecho en Alemania”, a German trade fair at the World Trade Center in Mexico City, where Bayer presented itself as a Life Science company. The five-day business exhibition attracted over 90,000 visitors. During the exhibition, Bayer was able to gain recognition as an attractive employer through its employer brand message “Passion to innovate | Power to change”. In fact, the company has been active in Mexico, the fifth largest country in North and South America, since 1959. With 3,150 employees and annual turnover of 18 billion pesos (around EUR 860 million), Mexico is an important factor in Bayer’s success.
21. Juli 2016

Twitter

Bayer   Q2: @Bayer4Crops business holds steady in a continuingly difficult market #environment
https://t.co/zfw9fDupNJ https://t.co/KvARwxVerh
27. Juli 2016
Bayer   Q2: Pharmaceuticals continues strong growth #trend
@BayerPharma
See full Interim #Report: https://t.co/zfw9fDupNJ https://t.co/2oX79jzvtX
27. Juli 2016
Bayer   Q2: Our #Life #Science businesses recorded encouraging #sales and earnings growth overall.
https://t.co/zfw9fDupNJ https://t.co/y45ZHruPFa
27. Juli 2016
Bayer   Q2: #Bayer raises #sales and #earnings
See Full Interim Report for Second Quarter 2016:
https://t.co/zfw9fDupNJ https://t.co/8QhOuaWJ1R
27. Juli 2016
Bayer   “Thanks to modern #medicine I’m #healthy, I’m happy & I’ve a new purpose & passion – my son.”https://t.co/9s4svTSZAe https://t.co/Kw16WMDKtr26. Juli 2016

Social Media

Bayer Karriere auf Facebook

Bayer ist einer der beliebtesten Arbeitgeber in Deutschland. Abonnieren Sie den Karriere-Kanal auf Facebook, um zu erfahren, was Sie von Bayer als Arbeitgeber erwarten können.

mehr

Publikationen

Zwischenbericht 2. Quartal 2016

Bayer ist im 2. Quartal 2016 mit Umsatz- und Ergebnisplus weiter gewachsen. Alle Fakten finden Sie im aktuellen Quartalsbericht.

mehr
Letzte Änderung: 27. Juli 2016 Copyright © Bayer AG
http://www.bayer.de